0001209191-21-051528.txt : 20210816 0001209191-21-051528.hdr.sgml : 20210816 20210816092417 ACCESSION NUMBER: 0001209191-21-051528 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210812 FILED AS OF DATE: 20210816 DATE AS OF CHANGE: 20210816 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: de Kruif John CENTRAL INDEX KEY: 0001790353 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37773 FILM NUMBER: 211174961 MAIL ADDRESS: STREET 1: C/O MERUS N.V. STREET 2: YALELAAN 62 CITY: UTRECHT STATE: P7 ZIP: 3584 CM ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merus N.V. CENTRAL INDEX KEY: 0001651311 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: YALELAAN 62 CITY: 3584 CM UTRECHT STATE: P7 ZIP: 3584 CM BUSINESS PHONE: 31 030 253 8800 MAIL ADDRESS: STREET 1: YALELAAN 62 CITY: 3584 CM UTRECHT STATE: P7 ZIP: 3584 CM FORMER COMPANY: FORMER CONFORMED NAME: Merus B.V. DATE OF NAME CHANGE: 20150819 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-08-12 0 0001651311 Merus N.V. MRUS 0001790353 de Kruif John C/O MERUS N.V. YALELAAN 62 UTRECHT P7 3584 CM NETHERLANDS 0 1 0 0 SVP & Chief Technology Officer Common Shares 2021-08-12 4 M 0 3333 A 15830 D Common Shares 2021-08-12 4 M 0 2239 A 18069 D Common Shares 2021-08-12 4 S 0 2787 19.34 D 15282 D Share Option (right to buy) 2021-08-12 4 M 0 3333 0.00 D 2022-06-17 Common Shares 3333 0 D Share Option (right to buy) 2021-08-12 4 M 0 2239 0.00 D 2023-03-16 Common Shares 2239 0 D This transaction was effected pursuant to a Rule 10b5-1 trading plan. Exercise price is denominated in Euros at 1.93. Amount represents the weighted average price of shares sold, which ranged from $19.20 to $19.425. Details of individual transactions are available upon request. These options are fully vested. Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on June 17, 2014. Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on March 16, 2015. /s/ Peter Silverman as attorney-in-fact 2021-08-16